Octapharma – Booth #309
Octapharma has been committed to patient care since 1983. Our core focus is the development and production of human plasma proteins from human plasma and human cell lines. Octapharma employs more than 9,000 people worldwide to support the treatment of patients in 118 countries with coagulation disorders, immune disorders, and other critical illnesses.